Skip to content
★ Sign in to follow
GH

Gary H. Rabin

CFO
Ocata Therapeutics, Inc.
Total declarations
38
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (34 ops.)
€1.4M

Latest filing published 15 Apr 2013 for Ocata Therapeutics, Inc., €36k.

Insider track record

Disclosed buys
0
Disclosed sells
34
Signal history

No signal scores available.

Gary H. Rabin: trading record in brief

All filings by Gary H. Rabin on record concern Ocata Therapeutics, Inc. The record holds 38 filings, for trades running from 4 February 2010 to 10 January 2013.

On the market, this insider has only sold: 34 sales, €1.4M in total. Other entries cover 4 share grants. Since January 2013: no purchases and 27 sales on the market.

Most recently, on 15 April 2013, the filings show an open-market sale worth €36k in Ocata Therapeutics, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Gary H. Rabin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations38 total

25 of 38 declarations